220 related articles for article (PubMed ID: 33583332)
1. Hydroxychloroquine Sulfate Related Hypoglycemia In A Non-Diabetic COVİD-19 Patient: A Case Report and Literature Review.
Imanova Yaghji N; Kan EK; Akcan S; Colak R; Atmaca A
Postgrad Med; 2021 Jun; 133(5):548-551. PubMed ID: 33583332
[No Abstract] [Full Text] [Related]
2. Hypoglycemia Induced by Hydroxychloroquine Sulfate in a Patient Treated for Connective Tissue Disease Without Diabetes Mellitus.
Dai Y; Lin G; Shi D
Clin Ther; 2020 May; 42(5):940-945. PubMed ID: 32336573
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
5. Review on the Clinical Pharmacology of Hydroxychloroquine Sulfate for the Treatment of COVID-19.
Cui C; Tu S; En VSJ; Li X; Yao X; Li H; Liu D
Curr Drug Metab; 2020; 21(6):427-435. PubMed ID: 32520683
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL
J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
Zang Y; Han X; He M; Shi J; Li Y
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):775-782. PubMed ID: 32892293
[TBL] [Abstract][Full Text] [Related]
11. Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine.
Tanaka T; Okamoto M; Matsuo N; Naitou-Nishida Y; Nouno T; Kojima T; Nishii Y; Uchiyashiki Y; Takeoka H; Nagasaki Y
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984543
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
Eljaaly K; Alireza KH; Alshehri S; Al-Tawfiq JA
Travel Med Infect Dis; 2020; 36():101812. PubMed ID: 32645478
[TBL] [Abstract][Full Text] [Related]
13. A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report.
Falcão F; Viegas E; Carmo I; Soares J; Falcao M; Solano M; Cavaco P; Mendes D; Rijo J; Povoa P; Pais Martins A; Carmo E; Mansinho K; Fonseca C; Campos L; Carvalho A; Mirco A; Farinha H; Aldir I; Correia J
Eur J Hosp Pharm; 2021 Sep; 28(5):248-253. PubMed ID: 33452110
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting.
Mokhtari M; Mohraz M; Gouya MM; Namdari Tabar H; Tabrizi JS; Tayeri K; Aghamohamadi S; Rajabpoor Z; Karami M; Raeisi A; Rahmani H; Khalili H
Int Immunopharmacol; 2021 Jul; 96():107636. PubMed ID: 34015598
[TBL] [Abstract][Full Text] [Related]
15. Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients.
Ferron PJ; Le Daré B; Bronsard J; Steichen C; Babina E; Pelletier R; Hauet T; Morel I; Tarte K; Reizine F; Clément B; Fromenty B; Gicquel T
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008505
[TBL] [Abstract][Full Text] [Related]
16. Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
Onori ME; Ricciardi Tenore C; Urbani A; Minucci A
Mol Biol Rep; 2021 Mar; 48(3):2973-2978. PubMed ID: 33620659
[TBL] [Abstract][Full Text] [Related]
17. Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial.
Davoodi L; Abedi SM; Salehifar E; Alizadeh-Navaei R; Rouhanizadeh H; Khorasani G; Hosseinimehr SJ
Int J Clin Pract; 2020 Nov; 74(11):e13600. PubMed ID: 32603531
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine in Treatment of Asymptomatic and Mildly Symptomatic COVID-19: A Multi-Centre Cohort Study.
Jain S; Sharma SK; Suri V; Yaddanapudi N; Malhotra P; Bhalla A; Singh MP; Koushal V; Kajal K; Jakulla RS; Marrapu S; Guru RR; Bora I; Chopra V; Sibia R; Puri GD
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062802
[TBL] [Abstract][Full Text] [Related]
19. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
Million M; Lagier JC; Tissot-Dupont H; Ravaux I; Dhiver C; Tomei C; Cassir N; Delorme L; Cortaredona S; Amrane S; Aubry C; Bendamardji K; Berenger C; Doudier B; Edouard S; Hocquart M; Mailhe M; Porcheto C; Seng P; Triquet C; Gentile S; Jouve E; Giraud-Gatineau A; Chaudet H; Camoin-Jau L; Colson P; Gautret P; Fournier PE; Maille B; Deharo JC; Habert P; Gaubert JY; Jacquier A; Honore S; Guillon-Lorvellec K; Obadia Y; Parola P; Brouqui P; Raoult D
Rev Cardiovasc Med; 2021 Sep; 22(3):1063-1072. PubMed ID: 34565108
[TBL] [Abstract][Full Text] [Related]
20. The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
Lee Z; Rayner CR; Forrest JI; Nachega JB; Senchaudhuri E; Mills EJ
Am J Trop Med Hyg; 2021 Jan; 104(1):35-38. PubMed ID: 33236703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
